aldosterone antagonists
Showing 1 - 25 of 1,053
Renin Angiotensin Aldosterone System Genetic Polymorphism on
Recruiting
- Myocardial Infarction
-
Cairo, EgyptAin Shams University
May 16, 2023
Outcome of Patients With Primary Aldosteronism
Recruiting
- Primary Aldosteronism
- +8 more
- Unilateral adrenalectomy in patients with unilateral disease
-
Singapore, SingaporeChangi General Hospital
Aug 10, 2021
Heart Failure, Hyperkalemia Trial in Gothenburg (Sodium zirconium cyclosilicate, Placebo)
Recruiting
- Heart Failure
- Hyperkalemia
- Sodium zirconium cyclosilicate
- Placebo
-
Gothenburg, SwedenSahlgrenska University Hospital-Ostra Hospital
Sep 20, 2021
Heart Failure Trial (Aldosterone Antagonists)
Unknown status
- Heart Failure
- Aldosterone Antagonists
- (no location specified)
Jan 7, 2020
Primary Aldosteronism, Endocrine Hypertension Trial (Cinnarizine, NIFEdipine ER)
Not yet recruiting
- Primary Aldosteronism
- Endocrine Hypertension
- Cinnarizine
- NIFEdipine ER
- (no location specified)
Jan 12, 2023
Primary Aldosteronism, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral) Trial in Boston (Amlodipine)
Recruiting
- Primary Aldosteronism
- Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
-
Boston, MassachusettsAnand Vaidya
Nov 26, 2021
Acute Decompensated Heart Failure Trial in La Jolla (Placebo, Metolazone)
Withdrawn
- Acute Decompensated Heart Failure
- Placebo
- Metolazone
-
La Jolla, CaliforniaScripps Green Torrey Pines
Nov 21, 2022
Pulmonary Hypertension Trial in Nanjing (Pulmonary arterial denervation, Standard treatment)
Completed
- Pulmonary Hypertension
- Pulmonary arterial denervation
- Standard treatment
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Jul 29, 2019
Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral) Trial in Nanchang (superselective adrenal arterial embolization)
Enrolling by invitation
- Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
- superselective adrenal arterial embolization
-
Nanchang, Jiagxi, Chinathe Second Affiliated Hospital of Nanchang University
Jul 19, 2022
Primary Aldosteronism Trial (Super selective adrenal artery embolization, Spironolactone)
Not yet recruiting
- Primary Aldosteronism
- Super selective adrenal artery embolization
- Spironolactone
- (no location specified)
Aug 12, 2022
Metabolic Syndrome, Hypertension, Overweight and Obesity Trial in Boston (Eplerenone, Chlorthalidone with potassium chloride)
Recruiting
- Metabolic Syndrome
- +2 more
- Eplerenone
- Chlorthalidone with potassium chloride
-
Boston, MassachusettsBrigham and Women's Hospital
Feb 28, 2022
Primary Hyperaldosteronism Due to Adrenal Adenoma Trial in Gothenburg, Stockholm, Umeå (Unilateral adrenalectomy, Medical
Not yet recruiting
- Primary Hyperaldosteronism Due to Adrenal Adenoma
- Unilateral adrenalectomy
- Medical treatment (eplerenone)
-
Gothenburg, Sweden
- +2 more
Mar 30, 2023
Hypertension Trial in Dallas (DEFINITY® infusion, Human Recombinant Regular Insulin infusion, Dextrose infusion)
Recruiting
- Hypertension
- DEFINITY® infusion
- +6 more
-
Dallas, TexasUT Southwestern Medical Center
Mar 22, 2022
Heart Failure Trial in Gallup (EHR-based GDMT Optimization)
Not yet recruiting
- Heart Failure
- EHR-based GDMT Optimization
-
Gallup, New MexicoGallup Indian Medical Center
Mar 17, 2023
Kidney Failure, Chronic Trial in Pittsburgh (Spironolactone)
Withdrawn
- Kidney Failure, Chronic
-
Pittsburgh, PennsylvaniaAllegheny General Hospital
Nov 29, 2021
Endstage Renal Disease Trial in Worldwide (Spironolactone 25Mg Tablet, Placebo Oral Tablet)
Recruiting
- Endstage Renal Disease
- Spironolactone 25Mg Tablet
- Placebo Oral Tablet
-
Garran, Australian Capital Territory, Australia
- +85 more
Sep 19, 2022
Breast Cancer, Cardiotoxicity Trial in United States (antihypertensive medications, Blood pressure measurement, Echocardiogram)
Recruiting
- Breast Cancer
- Cardiotoxicity
- antihypertensive medications
- +5 more
-
Basking Ridge, New Jersey
- +6 more
Aug 29, 2023
Atrial Fibrillation Trial in Netherlands, United Kingdom (Upstream therapy, Conventional rhythm control)
Completed
- Atrial Fibrillation
- Upstream therapy
- Conventional rhythm control
-
Almelo, Netherlands
- +19 more
Aug 17, 2021
Heart Failure Trial in Atlanta (Thyroid hormone T3, Control Group)
Recruiting
- Heart Failure
- Thyroid hormone T3
- Control Group
-
Atlanta, Georgia
- +1 more
Nov 14, 2022
SAAE on Vascular Endothelial Function in PA Patients
Recruiting
- Primary Aldosteronism
- Super selective adrenal artery embolization
- Spironolactone
-
Nanchang, ChinaThe Second Affiliated Hospital of Nanchang University
Dec 12, 2022
Endovascular Thrombectomy Trials Into Real-world Practice in
Recruiting
- Ischemic Stroke
- +5 more
- Thrombus analyses
- Imaging assessment
-
Linyi, Shandong, China
- +2 more
Nov 23, 2022
Hypertension, Hyperaldosteronaemia Trial (Spironolactone, Finerenone, Blank control)
Not yet recruiting
- Hypertension
- Hyperaldosteronaemia
- Spironolactone
- +2 more
- (no location specified)
Jan 15, 2023
The Effect of RAAS Blockers on ACE2 Levels
Completed
- Renin-Angiotensin System
- ACE inhibitor ,angiotensin receptor blockers
-
Cairo, Select A State Or Province, EgyptAinshams University
Jun 10, 2022
Study of Adrenal Gland Tumors
Completed
- Adrenal Gland Neoplasm
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023